Suppr超能文献

肥大细胞密度及其在华氏巨球蛋白血症中的临床相关性。

Mast cell density and its clinical relevance in Waldenström's macroglobulinemia.

作者信息

Lemal Richard, Poulain Stéphanie, Ledoux-Pilon Albane, Veronese Lauren, Tchirkov Andrei, Lebecque Benjamin, Tassin Thomas, Bay Jacques-Olivier, Charlotte Frédéric, Nguyen-Khac Florence, Berger Marc, Godfraind Catherine, Ysebaert Loïc, Davi Frédéric, Pereira Bruno, Leblond Véronique, Hermine Olivier, Guièze Romain, Pagès Franck, Tournilhac Olivier

机构信息

Laboratoire d'Histocompatibilité, Centre de Biologie, CHU de Clermont-Ferrand Université Clermont Auvergne Clermont Ferrand France.

Hématologie Clinique et Thérapie Cellulaire CHU Clermont-Ferrand EA7453 CHELTER CIC1405 Université Clermont Auvergne Clermont Ferrand France.

出版信息

EJHaem. 2022 Feb 8;3(2):371-378. doi: 10.1002/jha2.378. eCollection 2022 May.

Abstract

The presence of numerous mast cells (MCs) mixed with tumor cells in the bone marrow (BM) is a hallmark of the diagnosis of Waldenström's macroglobulinemia (WM). MCs have been shown to support lymphoplasmacytic cell growth, but there is thus far no demonstration of the prognostic impact of BM MC density in WM. We investigated BM MC density by sensitive and specific digital quantification, allowing the analysis of a large area infiltrated by BM tumor cells. A total of 65 WM patients were investigated, including 54 at diagnosis and 11 at relapse. Tryptase and CD20 immunohistochemisty staining was performed on contiguous sections of deparaffinized BM trephine biopsies. After numerization of each section, the BM surface area was manually marked out, excluding the bone framework and adipocytes to limit the analyses to only hematopoietic tissue. MCs were assessed using a digital tool previously used to quantify immune-cell infiltrates on tumor-tissue sections. Deep next-generation sequencing and allele-specific PCR were used to explore the and mutational status. MC density was heterogeneous among the WM patients. An optimal MC density threshold (> 56 MC.mm) was defined according to ROC curve analysis of overall survival. A higher MC density (> 56 MC.mm) was associated with greater BM involvement by WM lymphoplasmacytic cells and less hepatosplenic involvement ( = 0.023). Furthermore, MC density significantly correlated with a higher ISSWM score ( = 0.0003) in symptomatic patients. Patients with a higher MC density showed shorter median OS (56.5 months vs. nonreached,  = 0.0004), even in multivariate analysis after controlling for other predictive variables, such as age, ISSWM score, and mutational status. In conclusion, MC density can be accurately measured in WM patients using a specific digital tool on well-outlined hematopoietic tissue surfaces. High MC density is associated with aggressive features and a poor clinical outcome, emphasizing the need for further investigation of the involvement of MCs in the pathophysiology of WM.

摘要

骨髓(BM)中存在大量与肿瘤细胞混合的肥大细胞(MCs)是诊断华氏巨球蛋白血症(WM)的一个标志。MCs已被证明可支持淋巴浆细胞生长,但迄今为止,尚无证据表明BM中MC密度对WM有预后影响。我们通过灵敏且特异的数字定量法研究了BM中MC密度,从而能够分析被BM肿瘤细胞浸润的大片区域。共对65例WM患者进行了研究,其中54例为初诊患者,11例为复发患者。对脱钙的BM环钻活检连续切片进行类胰蛋白酶和CD20免疫组化染色。在对每一片进行计数后,人工划出BM表面积,排除骨框架和脂肪细胞,以便将分析仅局限于造血组织。使用先前用于量化肿瘤组织切片上免疫细胞浸润的数字工具评估MCs。采用深度二代测序和等位基因特异性PCR探索 和 突变状态。WM患者的MC密度存在异质性。根据总生存的ROC曲线分析确定了一个最佳MC密度阈值(>56个MC/mm)。较高的MC密度(>56个MC/mm)与WM淋巴浆细胞对BM的累及程度更高以及肝脾累及程度更低相关(P = 0.023)。此外,在有症状的患者中,MC密度与较高的国际分期系统(ISSWM)评分显著相关(P = 0.0003)。MC密度较高的患者中位总生存期较短(56.5个月 vs. 未达到,P = 0.0004),即使在控制了其他预测变量(如年龄、ISSWM评分和 突变状态)后的多变量分析中也是如此。总之,使用特定数字工具在轮廓清晰的造血组织表面能够准确测量WM患者的MC密度。高MC密度与侵袭性特征和不良临床结局相关,这强调了进一步研究MCs在WM病理生理学中作用的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3fd/9176068/a00cc8286a95/JHA2-3-371-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验